Double maintains 3 strategies that include NEO - NeoGenomics, Inc.
Current Value
$7.851 Year Return
Current Value
$7.851 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
YORW | 0.03% | $469.88M | -15.42% | 2.64% |
LFVN | -0.04% | $158.74M | +75.02% | 1.27% |
VOD | 0.06% | $23.04B | -5.41% | 7.74% |
LITB | -0.08% | $21.28M | -72.45% | 0.00% |
HRL | -0.09% | $16.59B | -16.43% | 3.81% |
CNP | 0.11% | $24.30B | +24.35% | 2.82% |
UL | 0.16% | $154.65B | +14.37% | 3.06% |
AMSF | 0.16% | $905.27M | +7.85% | 3.16% |
PRPH | 0.18% | $16.53M | -92.27% | 0.00% |
BJ | 0.26% | $14.71B | +39.60% | 0.00% |
SJM | -0.26% | $11.99B | -2.62% | 3.86% |
ORLY | -0.27% | $78.08B | +36.20% | 0.00% |
HAIN | -0.31% | $162.46M | -75.84% | 0.00% |
D | 0.32% | $46.94B | +3.26% | 4.86% |
NVS | -0.35% | $205.81B | +5.62% | 3.69% |
ADC | 0.38% | $8.13B | +22.47% | 4.08% |
CCK | -0.39% | $11.59B | +16.81% | 1.28% |
IFRX | 0.39% | $119.50M | +22.76% | 0.00% |
TU | -0.43% | $23.77B | -4.62% | 7.19% |
CECO | -0.44% | $926.84M | +3.75% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -36.18% | $361.41M | 1.43% |
VIXY | -29.15% | $109.64M | 0.85% |
TAIL | -26.07% | $140.49M | 0.59% |
BUXX | -14.68% | $284.43M | 0.25% |
FXY | -11.78% | $838.61M | 0.4% |
USDU | -11.44% | $173.44M | 0.5% |
STPZ | -11.18% | $446.46M | 0.2% |
IVOL | -10.86% | $353.94M | 1.02% |
XONE | -10.27% | $603.24M | 0.03% |
FTSD | -9.59% | $212.46M | 0.25% |
CTA | -9.38% | $1.05B | 0.76% |
UUP | -9.24% | $292.27M | 0.77% |
SCHO | -8.77% | $10.87B | 0.03% |
SHYM | -8.34% | $322.93M | 0.35% |
SPTS | -8.20% | $5.76B | 0.03% |
ULST | -8.16% | $637.77M | 0.2% |
TBLL | -8.14% | $2.46B | 0.08% |
GBIL | -7.66% | $6.17B | 0.12% |
TBIL | -7.17% | $5.76B | 0.15% |
VTIP | -6.68% | $14.78B | 0.03% |
Yahoo
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
Yahoo
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 7.5% year on year to $168 million. On the other hand, the company’s full-year revenue guidance of $753 million at the midpoint came in 2% above analysts’ estimates. Its non-GAAP loss of $0 per share was in line with analysts’ consensus estimates.
Yahoo
Investors who take an interest in NeoGenomics, Inc. ( NASDAQ:NEO ) should definitely note that the Chief Financial...
Yahoo
NeoGenomics ( NASDAQ:NEO ) First Quarter 2025 Results Key Financial Results Revenue: US$168.0m (up 7.5% from 1Q 2024...
Yahoo
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Yahoo
Morgan Stanley lowered the firm’s price target on NeoGenomics (NEO) to $10 from $17 and keeps an Equal Weight rating on the shares. The company’s Q1 miss was primarily driven by lower non-clinical revenue and lower than expected average unit price, says the analyst, who sees “more questions than answers” following the company’s quarterly report. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analys
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ARKG | 45.19% | $944.78M | 0.75% |
CPRJ | 44.15% | $48.43M | 0.69% |
KJUL | 44.01% | $113.35M | 0.79% |
IWC | 43.62% | $766.88M | 0.6% |
FYX | 43.40% | $811.75M | 0.6% |
GSSC | 43.31% | $538.65M | 0.2% |
VTWO | 43.23% | $12.07B | 0.07% |
IWM | 43.17% | $63.95B | 0.19% |
IWO | 43.03% | $11.36B | 0.24% |
IJT | 42.84% | $6.01B | 0.18% |
IWN | 42.62% | $11.10B | 0.24% |
PRFZ | 42.56% | $2.33B | 0.34% |
SLYG | 42.51% | $3.31B | 0.15% |
XHE | 42.43% | $171.93M | 0.35% |
KJAN | 42.39% | $305.13M | 0.79% |
GNOM | 42.36% | $40.65M | 0.5% |
SCHA | 42.09% | $16.91B | 0.04% |
SPSM | 42.08% | $11.14B | 0.03% |
VIOO | 41.83% | $2.88B | 0.1% |
IJR | 41.78% | $79.01B | 0.06% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SPSK | <0.01% | $307.27M | 0.5% |
TIPZ | 0.06% | $96.06M | 0.2% |
AGGH | 0.06% | $309.35M | 0.29% |
TLH | 0.08% | $9.85B | 0.15% |
USTB | 0.09% | $1.19B | 0.35% |
TIPX | -0.09% | $1.64B | 0.15% |
SOYB | 0.11% | $25.54M | 0.22% |
TLT | 0.16% | $47.60B | 0.15% |
DFIP | -0.22% | $875.64M | 0.11% |
UITB | 0.30% | $2.42B | 0.39% |
SPTL | -0.31% | $10.96B | 0.03% |
ZROZ | -0.31% | $1.44B | 0.15% |
IBD | 0.35% | $380.12M | 0.43% |
VGLT | -0.39% | $9.57B | 0.04% |
EDV | -0.40% | $3.32B | 0.05% |
JPLD | -0.43% | $1.19B | 0.24% |
STXT | 0.46% | $134.15M | 0.49% |
UBND | 0.54% | $727.50M | 0.4% |
GSY | -0.63% | $2.79B | 0.22% |
AGZD | 0.65% | $127.42M | 0.23% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -20.40% | $22.95B | +20.67% | 1.12% |
CME | -16.08% | $98.74B | +28.80% | 3.84% |
ED | -15.91% | $36.75B | +5.26% | 3.28% |
VZ | -15.88% | $183.32B | +8.02% | 6.21% |
AEP | -14.53% | $54.28B | +9.80% | 3.61% |
KMB | -11.52% | $45.57B | +1.99% | 3.58% |
CL | -11.50% | $72.64B | -5.18% | 2.25% |
CHD | -10.98% | $23.29B | -11.36% | 1.23% |
PPC | -10.30% | $11.21B | +41.54% | 0.00% |
SO | -10.08% | $96.04B | +10.08% | 3.29% |
PG | -10.07% | $380.78B | -3.25% | 2.51% |
KR | -10.05% | $44.68B | +24.17% | 1.89% |
MRK | -9.58% | $187.83B | -42.85% | 4.24% |
AWK | -9.55% | $27.37B | +4.54% | 2.22% |
FMTO | -9.46% | $45.74M | -99.96% | 0.00% |
RPRX | -8.76% | $13.96B | +18.79% | 2.55% |
EXC | -8.40% | $43.84B | +12.45% | 3.59% |
AMT | -8.32% | $99.10B | +8.59% | 3.09% |
SBAC | -8.31% | $24.62B | +12.92% | 1.76% |
AQB | -8.12% | $2.96M | -61.58% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KFRC | 51.43% | $781.34M | -35.59% | 3.64% |
LGIH | 49.95% | $1.34B | -45.64% | 0.00% |
PDM | 48.82% | $858.42M | -4.43% | 7.24% |
RGEN | 45.05% | $6.93B | -27.93% | 0.00% |
CNO | 43.05% | $3.84B | +34.50% | 1.65% |
HLMN | 42.93% | $1.60B | -15.01% | 0.00% |
CYRX | 42.78% | $337.42M | -50.73% | 0.00% |
VRTS | 41.61% | $1.22B | -25.02% | 4.88% |
OLO | 41.22% | $1.54B | +86.64% | 0.00% |
UFPI | 40.87% | $6.12B | -15.17% | 1.32% |
ALGN | 39.79% | $13.53B | -31.74% | 0.00% |
FLGT | 39.76% | $610.09M | -10.93% | 0.00% |
ENOV | 39.50% | $2.04B | -31.55% | 0.00% |
TPH | 39.42% | $2.87B | -20.58% | 0.00% |
ENVA | 39.34% | $2.47B | +58.92% | 0.00% |
TRU | 39.26% | $17.80B | +15.73% | 0.47% |
ABG | 39.21% | $4.59B | -4.18% | 0.00% |
HSII | 39.17% | $890.41M | +21.05% | 1.74% |
FIBK | 38.95% | $2.90B | +0.14% | 6.82% |
MAC | 38.93% | $4.01B | -1.24% | 4.27% |